Bayer’s Monsanto deal and Brexit are huge, dangerous bets (subscription required)
Bayer’s shareholders are likely to end up disappointed by the company’s $66bn takeover of Monsanto, just as many of the 17.4m Brits who voted to leave the EU will probably end up disillusioned too. A recent study of 2,500 corporate takeovers, discussed in the Harvard Business Review by Alan Lewis and Dan McKone of LEK Consulting, found that more than 60 per cent of acquisitions destroyed shareholder value.
